Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle [published January 16, 2020]. J Med Virol 2020. DOI: 10.1002/jmv.25678.
DOI: 10.1002/jmv.25678

Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989

Zhu N, Zhang D, Wang W et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019 [published January 24, 2020]. N Engl J Med 2020; 382: 727-33. DOI: 10.1056/NEJMoa2001017.
DOI: 10.1056/NEJMoa2001017

World Health Organization. Novel coronavirus (2019-nCoV): situation report - 39. Accessed February 28, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200228-sitrep-39-covid-19.pdfhttps://www.who.int/docs/default-source/coronaviruse/situation-reports/20200228-sitrep-39-covid-19.pdf

Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [published January 29, 2020]. Lancet 2020. DOI: 10.1016/S0140-6736(20)30211-7.
DOI: 10.1016/S0140-6736(20)30211-7

Van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020 Mar 17. DOI: 10.1056/NEJMc2004973.
DOI: 10.1056/NEJMc2004973

Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet 2020.

Zhang H, Kang Z, Gong H et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv 2020. https://doi.org/10.1101 /2020.01.30.927806.
DOI: 10.1101 /2020.01.30.927806

Cheng-wei Lu, Xiu-fen Liu, Zhi-fang Jia. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395 (10224): e39. DOI: 10.1016/S0140-6736(20)30313-5.
DOI: 10.1016/S0140-6736(20)30313-5

Mahase E. China coronavirus: what do we know so far? BMJ 2020; 368: m308.

Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 2020; 395. Issue 10225: 689-97.

Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020. DOI: 10.1016/S0140-6736(20)30251 -8.
DOI: 10.1016/S0140-6736(20)30251 -8

Sahrabi C et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surgery 2020. https://doi.org/10.1016Zj.ijsu.2020.02.034.
DOI: 10.1016Zj.ijsu.2020.02.034

Kannan S et al. COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 2020; 24 (4): 2006-11. DOI: 10.26355/eurrev_202002_20378.
DOI: 10.26355/eurrev_202002_20378

Cascella M, Rajnik M, Cuomo A et al. Features, Evaluation and Treatment Coronavirus (COVID-19). Last Update: March 20, 2020. https://www.ncbi.nlm.nih.gov/books/NBK554776/https://www.ncbi.nlm.nih.gov/books/NBK554776/

WHO. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Geneva: WHO; 2020. [Accessed on 1 March 2020.] https://www.who.int/docs/default-source/ coronaviruse/who-china-joint-mission-on-covid-19-nal-report.pdfhttps://www.who.int/docs/default-source/

Korea Centers for Disease Control & Prevention (KCDC). The updates of COVID-19 in Republic of Korea as of 26 February, 2020. Osong, Republic of Korea: KCDC; 2020. [Accessed on 1 March 2020.] https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view&list_no=366352https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view&list_no=366352

Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.

Qingmei H, Qingqing L, Shenhe J, Liangshun Y. Recent insights into 2019-nCoV: a brief but comprehensive review. J Infect 2020. DOI: https://doi.org/10.1016/jjinf.2020.02.010.
DOI: 10.1016/jjinf.2020.02.010

Commun Dis Intell 2020; 44. https://doi.org/10.33321/cdi.2020.44.14.
DOI: 10.33321/cdi.2020.44.14

Dawei Wang et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus - Infected Pneumonia in Wuhan, China. JAMA 2020. DOI: 10.1001/jama.2020.1585.
DOI: 10.1001/jama.2020.1585

Ai T, Yang Z, Hou H et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020: 200642. DOI: 10.1148/radiol. 2020200642.
DOI: 10.1148/radiol. 2020200642

Lin X et al. Novel Coronavirus Pneumonia Outbreak in 2019: Computed Tomographic Findings in Two Cases. Korean J Radiol 2020; 21 (3): 365-8. DOI: 10.3348/kjr.2020.0078. Epub 2020 Feb 11..
DOI: 10.3348/kjr.2020.0078. Epub 2020 Feb 11

Wei J et al. 2019 Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings. Korean J Radiol 2020. https://doi.org/10.3348/kjr.2020.0112.
DOI: 10.3348/kjr.2020.0112

Bernheim A, Mei X, Huang M et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020; p. 200463. doi: 10.1148/radiol.2020200463.
DOI: 10.1148/radiol.2020200463

Rodrigues JCL et al. An update on COVID-19 for the radiologist - A British society of Thoracic Imaging statement, Clinical Radiology. https://doi.org/10.1016j.crad.2020.03.003.
DOI: 10.1016j.crad.2020.03.003

Wei Liu et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese Med J 2020. DOI: 10.1097/CM9.0000000000000775.
DOI: 10.1097/CM9.0000000000000775

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19). China, 2020. China CDC Weekly. Accessed February 20, 2020. http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51

Yang J et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020. DOI: https://doi.org/10.1016/jtjid.2020.03.017.
DOI: 10.1016/jtjid.2020.03.017

Профилактика, диагностика и лечение новой коронавирусной инфекции (2019-nCoV). Временные методические рекомендации. Версия 4 (27.03.2020). Министерство здравоохранения Российской Федерации.

Centers for Disease Control and Prevention 2019 Novel Coronavirus (2020) https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html. World Health Organization Coronavirus Disease 2019 (COVID-19) Situation Report - 46 (2020).https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html

World Health Organization Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses (2013).

World Health Organization WHO Global Epidemiological Surveillance Standards for Influenza (2014).

Jin et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res 2020; 7: 4. https://doi.org/10.1186/s40779-020-0233-6.
DOI: 10.1186/s40779-020-0233-6

Kui L, Fang Y-Y, Deng Y et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020. DOI: 10.1097/CM9.0000000000000744.
DOI: 10.1097/CM9.0000000000000744

World Health Organization. Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance. 28 January 2020. WHO/nCoV/Clinical/2020.3

Chan KS, Lai ST, Chu CM et al. Treatment of severe acute respiratory syndrome with lopinavir/rito-navir: a multicenter retrospective matched cohort study. Hong Kong Med J 2003; 9 (6): 399-406.

Chu CM, Cheng VC, Hung IF et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004; 59 (3): 252-6.

Lai ST. Treatment of severe acute respiratory syndrome. Eur J Clin Microbiol Infect Dis 2005; 24 (9): 583-91.

Brigitte M, Arti B, Stephan A et al. MERSCOV disease associated ARDS - a case report. Crit Care Med 2015; 43 (12): 308.

Gautret P, Lagier J-C, Parola P et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of anopen-label non-randomized clinical trial. Int J Antimicrob Agents 2020. DOI: https://doi.org/10.1016/jtjantimicag.2020.
DOI: 10.1016/jtjantimicag.2020

Vincent MJ, Bergeron E, Benjannet S et al. Virol. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology J 2005.

World Health Organization. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. 2020. https://www.who.int/publications-detail/home-care-forpatients-with-suspected-novel coronavirus-(ncov)-infection-presenting-with-mildsymptoms-and-management-of-contacts. Accessed 24 Jan 2020.https://www.who.int/publications-detail/home-care-forpatients-with-suspected-novel

Wang Y, Lin LK. An advice guideline recommended by central south hospital for the suspected patients of novel coronavirus (2019-nCoV) infected pneumonia and their close contacts as at home quarantine 2020. https://mp.weixin.qq.com/s/xFO10WAFB9OUnM7VN92R2whttps://mp.weixin.qq.com/s/xFO10WAFB9OUnM7VN92R2w

Приложение к письму Роспотребнадзора от 25.01.2020 №02/877-2020-27. Предварительные рекомендации по предупреждению распространения новой коронавирусной инфекции (2019-nCoV) в медицинских организациях.